G1 Therapeutics Obtains $46,999,999 New Financing

  • Feed Type
  • Date
    5/11/2016
  • Company Name
    G1 Therapeutics
  • Mailing Address
    4401 Research Commons Research Triangle Park, NC 27709 USA
  • Company Description
    G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of first-in-class compounds and best-in-class drug candidates.
  • Website
    http://www.g1therapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $46,999,999
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 20 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy